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RESULTSBACKGROUND
Pregnant women experience extensive physiologic and structural
changes during pregnancy. Osteopathic manipulative medicine
(OMM) involves the examination of the whole patient, including
body, mind, and spirit. This involves treatment of any stresses
placed on the body, including the structural changes in the
maternal body. Clinical studies thus far on osteopathic
manipulative medicine in pregnancy have shown that when used
during pregnancy, it improves musculoskeletal pain such as low
back pain, and may positively affect some labor and delivery
outcomes, including the length of labor, perineal lacerations,
operative vaginal delivery, meconium-stained fluid, and infants’
APGAR scores.
Hypothesis: We hypothesize that the use of osteopathic
manipulative medicine in pregnancy increases the likelihood of a
vaginal delivery versus cesarean section.
A minimal number of OMM treatments that were performed
during the pregnancies of the patients included in this study did
not influence birth outcomes as expected. OMM during pregnancy
did not appear to have an impact on the mode of delivery or
infants APGAR scores. Meconium stained fluid and perineal
lacerations were decreased in the OMM treatment group
compared to the control group, however this did not appear to be
statistically significant.
Tobacco use was more commonly seen in the participants of the
control group when compared to the OMM treatment group. The
BMI of participants in the treatment group was higher than the
control group. These results indicate that various lifestyle choices
that were not evaluated in this study, such as mood, stress,
exercise, diet, and illicit drug use, may have an impact on type of
delivery and other delivery outcomes investigated in this study.
SUMMARY
METHODS
 OMM treatments during pregnancy (total of 1-6 time and
mean ± SD 1.1 ± 1.5) did not appear to have an impact on the
type of delivery or infants’ Apgar scores as comparing to the
controls.
 The BMI of participants in the treatment group was higher
than the control group (p<0.05).
Meconium-stained fluid and perineal lacerations were
decreased in the OMM treatment group compared to the
control group, however this was not statistically significant.
When comparing the age of participants in both groups,
there was no statistically significant difference found between
the two groups (P value 0.49).
CONCLUSIONS
A retrospective chart review was performed from 2013-2016 and
participants were selected based on the inclusion criteria, which
included nulliparous women between ages 15-35, delivery at full
term, and pregnancies without complications or labeled high
risk. This resulted in 42 participants in the OMM treatment group
and 58 participants in the control group. Univariate statistics and
Chi-square test, as well as descriptive statistics were used for data
analysis.
Comparing the outcomes between OMM and controls
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Patients with OMM and Controls 
OMM 
n=42
Controls 
n=58
P-Value
Age (yr.) 26.93 ± 6.01 26.14 ± 5.08 NS
BMI (kg/m2) 32.64 ± 6.54 29.81 ± 5.37 0.02
Number of OMM visits 2.60 ± 1.19 0 NS
Smoking n(%) 5 (11.9) 13 (22.41) NS
Patients in OMM group had higher BMI than the controls.
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